Supporting Statement A for
Request for Human Embryonic Stem Cell Line to be Approved
for Use in NIH Funded Research (OD)
OMB Control Number 0925-0601, exp., date 10/31/2022
August 22, 2022
Check off which applies:
New
Revision
Reinstatement with Change
Reinstatement without Change
X Extension
Emergency
Existing w/o OMB approval
Name: Ellen Gadbois
Address: Office of Science Policy
National Institutes of Health
Building 1, Room 281, MSC 0166
9000 Rockville Pike
Bethesda, MD 20892
Telephone: 301-594-2567
Fax: 301-402-0280
Email: ellen.gadbois@nih.gov
Table of contents
A. ABSTRACT
A.1 Circumstances Making the Collection of Information Necessary
A.2. Purpose and Use of the Information COLLECTION
A.3 Use of Information Technology and Burden Reduction
A.4 Efforts to Identify Duplication and Use of Similar Information
A.5 Impact on Small Businesses or Other Small Entities
A.6 Consequences of Collecting the Information Less Frequently
A.7 Special Circumstances Relating to the Guidelines of 5 CFR 1320.5
A.8 Comments in Response to the Federal Register Notice and Efforts to Consult Outside Agency
A.9 Explanation of Any Payment of Gift to Respondents
A.10 Assurance of Confidentiality Provided to Respondents
A.11 Justification for Sensitive Questions
A.12 Estimates of Hour Burden Including Annualized Hourly Costs
A.13 Estimate of Other Total Annual Cost Burden to Respondents or Record keepers
A.14 Annualized Cost to the Federal Government
A.15 Explanation for Program Changes or Adjustments
A.16 Plans for Tabulation and Publication and Project Time Schedule
A.17 Reason(s) Display of OMB Expiration Date is Inappropriate
A.18 Exceptions to Certification for Paperwork Reduction Act Submissions
Attachments:
Attachment 1 NIH Form 2890: Request for Human Embryonic Stem Cell Line to be Approved for Use in NIH Funded Research
Attachment 2 NIH Form 2890 Privacy Impact Assessment
Attachment 3 30-day Federal Register Notice
A. Justification
This is an extension of 0925-0601, Request for Human Embryonic Stem Cell Line to be Approved for Use in NIH Funded Research. Executive Order (EO) 13505 states that NIH may support and conduct responsible, scientifically worthy human stem cell research, including human embryonic stem cell (hESC) research. The NIH Guidelines for Human Stem Cell Research (Guidelines), implementing the EO, established an NIH Registry of eligible hESC lines that comply with the set of standards described in the Guidelines. The Request for Human Embryonic Stem Cell Line to be Approved for Use in NIH Funded Research will continue to be used by respondents who have hESC lines and wish for the lines to be approved for use in NIH funded research.
A.1 Circumstances Making the Collection of Information Necessary
President Barack H. Obama issued Executive Order (EO) 13505 Removing Barriers to Responsible Scientific Research Involving Human Stem Cells on March 9, 2009. The EO stated that the Secretary of Health and Human Services, through the Director of NIH, may support and conduct responsible, scientifically worthy human stem cell research, including human embryonic stem cell (hESC) research, to the extent permitted by law. The EO also directed the Secretary, through the Director of NIH, to review existing NIH guidance and other widely recognized guidelines on human stem cell research, including provisions establishing appropriate safeguards, and issue new NIH Guidelines on such research.
The NIH Guidelines for Human Stem Cell Research (Guidelines) implementing the EO and establishing policy and procedures under which the NIH will fund such research became effective on July 7, 2009, and are available at http://stemcells.nih.gov/policy/pages/2009guidelines.aspx. The Guidelines provide scientists who apply for NIH funding with a specific set of standards reflecting currently recognized ethical principles and practices specific to embryo donation, prescribe the assurances and supporting documentation necessary for NIH funding of research using hESCs, and describe research that is not eligible for NIH funding. The Guidelines established a new NIH Registry of eligible hESC lines that comply with the set of standards described in the Guidelines. NIH also posts information on cell lines that are not approved for use in NIH funding.
The Request for Human Embryonic Stem Cell Line to be Approved for Use in NIH Funded Research (hereafter referred to as Form 2890; see Attachment 1) will continue to be used by respondents who have hESC lines and wish for the lines to be approved for use in NIH funded research. NIH will continue to review the requests in accord with the NIH Guidelines, by either Administrative Review, or review by the Working Group of the Advisory Committee to the [NIH] Director. Those hESC lines that NIH determines meet the criteria of the Guidelines will continue to be posted on the NIH Registry and NIH funded researchers will continue to be required to reference the hESC lines from the Registry proposed to be used when applying to the NIH for research funding that involves the use of hESCs. The information also will be used for program management, as well as for reporting to Congress and to the public on hESC lines that are eligible for NIH funding. Applicants will cite the lines on the PHS 398 and 398 components and the PHS 416, approved by OMB under 0925-0001, Expiration Date: September 30, 2024; and the PHS 2590 and NIH Implementation of the Research Performance Progress Report (RPPR) approved by OMB under 0925-0002, Expiration Date: September 30, 2024. During the last three years, NIH has approved 77 hESC lines for use in NIH-funded research.
A.3 Use of Information Technology and Burden Reduction
Form 2890 will continue to be provided exclusively in a web-based format on the NIH web site, and electronic submission of the data-collection instrument is authenticated against personal profiles and sign-on credentials in the eRA Commons database. To the extent possible, data contained in the eRA Commons account of the respondent is used to pre-populate the respondent’s name, institution and contact information on Form 2890 to reduce the need for respondents to enter data already in an NIH system. The web-based Form 2890 is fully integrated with existing electronic systems to minimize the new data being collected. In addition, the NIH Registry is integrated with existing electronic systems used to support NIH grant application processes.
The IT System owner/manager conducted a Privacy Impact Assessment (see Attachment 2), which was reviewed and approved by the NIH Senior Official for Privacy and has been renewed yearly.
There is no duplication in data collection by NIH about hESC lines, and no changes regarding the collection of information are proposed in this extension request.
The procedures for small businesses and other small entities are the same as for other respondents and do not require special accommodation.
Form 2890 represents a one-time information collection. NIH decisions regarding the inclusion on the Registry of an hESC line as eligible for NIH funding are generally final.
No special circumstances are anticipated.
The 60-day FR Notice concerning Form 2890 was published on June 8, 2022, volume 87, number 110, pages 34892-34893 (87 FR 34892); no comments were received.
Within the last three years, Office of the Director staff have worked with several applicants to clarify the information requested in order for the review process to proceed.
A.9 Explanation of Any Payment of Gift to Respondents
There are no plans for payments or gifts to respondents.
A.10 Assurance of Confidentiality Provided to Respondents
Personally identifiable information stored in the eRA Commons database in association with the respondent is maintained in a Privacy Act record system (09-25-0225; Electronic Research Administration (eRA) Records, HHS/NIH/OD/OER). Information submitted to NIH via Form 2890 is subject to the Freedom of Information Act (FOIA). The Instructions to Form 2890 (see Attachment 1: NIH Form 2890) clearly notify respondents that all materials submitted or saved on the NIH server will be treated by NIH as information which may be made available to the public, and instructs them not to submit financial, commercial, confidential or proprietary information, including consent documents with the personally identifying information of donor(s) of embryos (the individuals who sought reproductive treatment). Submission of consent documents with such information will cause NIH to delete the submitted information from the NIH database and could invalidate the request.
A.11 Justification for Sensitive Questions
No questions of a sensitive nature are requested on Form 2890.
A.12.1 Estimates of Hour Burden Including Annualized Hourly Costs
The estimated number of respondents in this extension request is the same as in the most recent prior request.
Table 12-1 Estimated Annualized Burden Hours
Form Name |
Type of Respondents |
Number of Respondents |
Number of Responses per Respondent |
Average Burden Per Response (in hours) |
Total Annual Burden Hours |
2890 |
NIH grantees and others in possession of hESC lines |
5 |
3 |
17 |
255 |
Total |
|
|
15 |
|
255 |
A.12-2 Annual Cost to respondent
Type of Respondents |
Total Annual Burden Hours |
Mean Hourly Respondent Wage Rate* |
Respondent Cost |
NIH grantees and others in possession of hESC lines |
255 |
$38.81 |
$9,896.55 |
TOTAL |
|
|
$9,896.55 |
A.13 Estimate of Other Total Annual Cost Burden to Respondents or Record Keepers
There are no other costs, other than time, to participate.
The annualized cost to the government is $30,805.
Cost Descriptions |
|
Salary |
% of Effort |
Fringe (if applicable) |
Total Cost to Gov’t |
Grade/Step |
|||||
Federal Oversight |
|
|
|
|
|
NIH Senior Policy Analyst |
GS-15/Step 10 |
$176,300 |
10% |
|
$17,630 |
NIH Policy Analyst |
GS-13/Step 8 |
|
10% |
|
$13,175 |
Contractor Cost |
|
|
|
|
|
Total |
|
|
|
|
$30,805 |
*the Salary in table above is cited from https://www.opm.gov/policy-data-oversight/pay-leave/salaries-wages/salary-tables/pdf/2022/DCB.pdf
A.15 Explanation for Program Changes or Adjustments
This is an extension of a currently approved submission. There are no substantive changes to the data collection. The estimated number of respondents in this extension request is expected to be similar to the prior period.
This request is for approval of use of forms related to administration of PHS research programs; there is no tabulation, publication, or project time schedule. Data collection activities are ongoing.
A.17 Reason(s) Display of OMB Expiration Date is Inappropriate
None. The expiration date will be displayed on the main page of the web-based form.
A.18 Exceptions to Certification for Paperwork Reduction Act Submissions
None
| File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
| Subject | Supporting Statement A |
| Author | Lopez, Maria (NIH/NICHD) [E] |
| File Modified | 0000-00-00 |
| File Created | 2022-09-16 |